Skip To Main Content
Dania Nadeem on Muck Rack

Dania Nadeem

As seen in: G1 Globo, MSN, MSN Canada, Daily Mail, Reuters, Yahoo Canada, Yahoo News, Yahoo News Malaysia, Yahoo News UK, Yahoo Singapore and
News Editor at @SeekingAlpha, Ex- @Reuters, CNN-News18, Tiranga TV

Get in touch with Dania

Contact Dania, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Zepbound: A novel pharmacological approach to Obstructive Sleep Apnea management

|
By Muhammad Aamir, Hamdard College, Dania Nadeem, Alishba Inshal Qasim
| jpma.org.pk
Abstract Dear editor, In December 2024, the U.S. Food and Drug Administration (FDA) approved Zepbound (Tirzepatide) for the treatment of obstructive sleep apnea (OSA).(1) Tirzepatide is a dual receptor agonist for glucagon-like peptide-1 (GLP-1)and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, both of which are incretin hormones.
Open in Who Shared Issue with article?

Aquestive Therapeutics releases positive clinical data on anaphylm

|
By Dania Nadeem
| Seeking Alpha
May 31, 2023 11:07 AM ET
Open in Who Shared View Duplicates (10) Issue with article?

Advantex Marketing International GAAP EPS of $0.00, revenue of $0.5M (OTCMKTS:ATXMF)

|
By Dania Nadeem
| Seeking Alpha
Get expert analysis on your investments with Seeking Alpha Premium now »
Open in Who Shared View Duplicates (17) Issue with article?
See all 4,169 licensed articles (4,178 Total)